
-
1997
Company Description
Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.
-
Manufacturer:
Science and Engineering -
Formed:
1997 -
Company Website:
-
Company E-mail:
-
Company Address:
2901, Rachel Street East, #23, MontrealQuebec, QCCanada -
CEO:
- Robert Heft
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits